{
  "id": "Sokal_Index_for_CML.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2021-02-25",
      "name": "Emma Malm",
      "organisation": "Cambio CDS",
      "email": "emma.snygg@hotmail.com"
    },
    "lifecycle_state": "Initial",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To calculate the total sum for Sokal index. ",
        "keywords": [
          "CML",
          "leukemia",
          "sokal",
          "index",
          "myelogenous",
          "chronic"
        ],
        "use": "Use to predict the survival of CML. The Sokal index is calculated by using the following formula:\nSokal Score = exp([0.0116 × (age in years – 43.4)] + [0.0345 × (spleen size in cm – 7.51)] + [0.188 x ((platelets in 109/L / 700)2 – 0.563)] + [0.0887 × (blasts in % – 2.10)])\n\nInterpretation: \nRisk Group        Sokal Score        2-year Survival        Median Survival\nLow                   <0.8                    90%                         5 years\nIntermediate     0.8–1.2               65-90%                    2.5-5 years\nHigh                  >1.2                    65%                         2.5 years",
        "copyright": "Cambio CDS"
      }
    },
    "other_details": {
      "references": "Sokal JE, Cox EB, Baccarani M, Tura S, Gomez GA, Robertson JE, Tso CY, Braun TJ, Clarkson BD, Cervantes F, et al. Prognostic discrimination in \"good-risk\" chronic granulocytic leukemia. Blood. 1984 Apr;63(4):789-99. PMID: 6584184.\n\n\n\n"
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.sokal.v0",
        "template_id": "openEHR-EHR-OBSERVATION.sokal.v0",
        "type": "INPUT",
        "elements": {
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0010]"
          }
        }
      },
      "gt0006": {
        "id": "gt0006",
        "model_id": "openEHR-EHR-OBSERVATION.lab_test-full_blood_count.v1",
        "template_id": "openEHR-EHR-OBSERVATION.lab_test-full_blood_count.v1",
        "type": "INPUT",
        "elements": {
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0078.12]"
          },
          "gt0025": {
            "id": "gt0025",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0.27]"
          }
        }
      },
      "gt0010": {
        "id": "gt0010",
        "model_id": "openEHR-EHR-EVALUATION.sokal_assesment.v0",
        "template_id": "openEHR-EHR-EVALUATION.sokal_assesment.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0002]/items[at0003]"
          },
          "gt0013": {
            "id": "gt0013",
            "path": "/data[at0002]/items[at0007]"
          },
          "gt0014": {
            "id": "gt0014",
            "path": "/data[at0002]/items[at0011]"
          }
        }
      },
      "gt0019": {
        "id": "gt0019",
        "model_id": "openEHR-EHR-OBSERVATION.sokal.v0",
        "template_id": "openEHR-EHR-OBSERVATION.sokal.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0020": {
            "id": "gt0020",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0014]"
          }
        }
      },
      "gt0023": {
        "id": "gt0023",
        "model_id": "openEHR-EHR-OBSERVATION.basic_demographic.v1",
        "template_id": "openEHR-EHR-OBSERVATION.basic_demographic.v1",
        "type": "INPUT",
        "elements": {
          "gt0024": {
            "id": "gt0024",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0013]"
          }
        }
      }
    },
    "default_actions": [
      "$gt0016|Spleen size conversion factor|=1"
    ],
    "rules": {
      "gt0017": {
        "id": "gt0017",
        "priority": 5,
        "when": [
          "$gt0004|Spleen size |.unit=='in'"
        ],
        "then": [
          "$gt0016|Spleen size conversion factor|=2.53807"
        ]
      },
      "gt0015": {
        "id": "gt0015",
        "priority": 4,
        "when": [
          "$gt0024|Age|!=null",
          "$gt0004|Spleen size |!=null",
          "$gt0025|% myeloblasts|!=null",
          "$gt0007|Platelet count|!=null"
        ],
        "then": [
          "$gt0020|Sokal score|.magnitude=e^((0.0116*($gt0024.magnitude-43.4))+(0.0345*($gt0004.magnitude*$gt0016-7.51))+(0.188*(($gt0007.magnitude/700)^2-0.563))+(0.0887*($gt0025.magnitude-2.1)))",
          "$gt0020|Sokal score|.precision=1",
          "$gt0020|Sokal score|.unit='1'"
        ]
      },
      "gt0021": {
        "id": "gt0021",
        "priority": 3,
        "when": [
          "$gt0020|Sokal score|>1.2,1"
        ],
        "then": [
          "$gt0011|Risk Group|=local::at0006|High|",
          "$gt0013|2-year Survival|=local::at0010|65%|",
          "$gt0014|Median Survival|=local::at0014|2.5 years|"
        ]
      },
      "gt0022": {
        "id": "gt0022",
        "priority": 2,
        "when": [
          "$gt0020|Sokal score|>=0.8,1",
          "$gt0020|Sokal score|<=1.2,1"
        ],
        "then": [
          "$gt0011|Risk Group|=local::at0005|Intermediate|",
          "$gt0013|2-year Survival|=local::at0009|65-90%|",
          "$gt0014|Median Survival|=local::at0013|2.5-5 years|"
        ]
      },
      "gt0018": {
        "id": "gt0018",
        "priority": 1,
        "when": [
          "$gt0020|Sokal score|<0.8,1"
        ],
        "then": [
          "$gt0011|Risk Group|=local::at0004|Low|",
          "$gt0013|2-year Survival|=local::at0008|90%|",
          "$gt0014|Median Survival|=local::at0012|5 years|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Sokal Index for CML",
            "description": "Sokal Index for Chronic Myelogenous Leukemia (CML) predicts survival of CML based on clinical and lab information. "
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Spleen size ",
            "description": ""
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Platelet count",
            "description": "The number of platelets per liter"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Risk Group",
            "description": ""
          },
          "gt0013": {
            "id": "gt0013",
            "text": "2-year Survival",
            "description": ""
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Median Survival",
            "description": ""
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Calculate total score"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "Spleen size conversion factor",
            "description": ""
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Set Spleen size conversion factor"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Risk Group: Low"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "Sokal score",
            "description": ""
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Risk Group: High"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "Risk Group: Intermediate"
          },
          "gt0024": {
            "id": "gt0024",
            "text": "Age",
            "description": "Age in years, and for babies: months, weeks or days"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "% myeloblasts",
            "description": "The proportion of  immature white blood cells"
          }
        }
      }
    }
  }
}